Is BXRX or DVY a better dividend investment in 2026?

BXRX currently yields 9174.31% with a 5% 5-year dividend growth rate. DVY yields 3.50% with 5% growth. The better choice depends on your goal: BXRX offers higher current income.

What is the dividend yield difference between BXRX and DVY?

BXRX has a forward dividend yield of 9174.31% ($2.00/share annually). DVY yields 3.50% ($5.25/share annually). The yield gap is 9170.81 percentage points.

Home › Compare › BXRX vs DVY

BXRX vs DVY: Dividend Comparison 2026

BXRX yields 9174.31% · DVY yields 3.50%● Live data

vsPost on X →

After 10 years · $10,000 invested · DRIP enabled

🏆 BXRX wins by $23597687873458488.00M in total portfolio value

INVESTMENT

TIME HORIZON10 years

BXRX

● Live price

9174.31%

Share price

$0.02

Annual div

$2.00

5Y div CAGR

Payout ratio

50%

After 10 yrs · $10,000 · DRIP

Portfolio value

$23597687873458488.00M

Annual income

$23,102,328,897,111,608,000,000.00

Full BXRX calculator →

DVY

● Live price

3.50%

Share price

$150.03

Annual div

$5.25

5Y div CAGR

Payout ratio

50%

After 10 yrs · $10,000 · DRIP

Portfolio value

$25.1K

Annual income

$437.78

Full DVY calculator →

Portfolio growth — BXRX vs DVY

📍 BXRX pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis Period	BXRX	DVY
2008–2009 GFC	— No data	— No data
2020 Q1–Q2 COVID	— No data	— No data
2022 Q4 Rate Hike	— No data	— No data

Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.

📅

Dividend Calendar Overlap

Combined, BXRX + DVY cover 0 of 12 months — good coverage

Jan

—

Feb

—

Mar

—

Apr

—

May

—

Jun

—

Jul

—

Aug

—

Sep

—

Oct

—

Nov

—

Dec

—

BXRX pays

DVY pays

Both pay

Neither

💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

BXRX

Annual income on $10K today (after 15% tax)

$779,816.51/yr

After 10yr DRIP, annual income (after tax)

$19,636,979,562,544,865,000,000.00/yr

DVY

Annual income on $10K today (after 15% tax)

$297.17/yr

After 10yr DRIP, annual income (after tax)

$372.11/yr

At 15% tax rate, BXRX beats the other by $19,636,979,562,544,865,000,000.00/year in after-tax income after 10 years on $10,000

⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of BXRX + DVY for your $10,000?

BXRX: 50%DVY: 50%

100% DVY50/50100% BXRX

Portfolio after 10yr

$11798843936729244.00M

Annual income

$11,551,164,448,555,804,000,000.00/yr

Blended yield

97.90%

📊

Analyst Conviction Gap

Where Wall Street is most bullish on BXRX right now

BXRX

Analyst Ratings

Buy

Hold

Consensus: Buy

Altman Z

-15.9

Piotroski

1/9

DVY

No analyst data

Altman Z

307.5

Piotroski

1/9

Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.

🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

BXRX buys

DVY buys

No recent congressional trades found for BXRX or DVY in the last 90 days.

STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →

MetricBXRXDVY

Forward yield	9174.31% ✓	3.50%
Annual dividend / share	$2.00	$5.25 ✓
Payout ratio	50%	50%
1-year div growth	0%	0%
5-year div CAGR	0%	0%
Portfolio after 10y	$23597687873458488.00M ✓	$25.1K
Annual income after 10y	$23,102,328,897,111,608,000,000.00 ✓	$437.78
Total dividends collected	$23564675825677336.00M ✓	$4.0K
Payment frequency	quarterly	quarterly
Sector	Stock	ETF

Year-by-year: BXRX vs DVY ($10,000, DRIP)

Year	BXRX Portfolio	BXRX Income/yr	DVY Portfolio	DVY Income/yr	Gap
1← crossover	$928,131	$917,431.19	$11,050	$349.62	+$917.1K → BXRX
2	$80,572,213	$79,579,112.81	$12,184	$361.04	+$80.56M → BXRX
3	$6,542,624,325	$6,456,412,056.54	$13,409	$372.07	+$6542.61M → BXRX
4	$496,975,869,083	$489,975,261,055.26	$14,730	$382.68	+$496975.85M → BXRX
5	$35,315,297,301,597	$34,783,533,121,678.35	$16,154	$392.89	+$35315297.29M → BXRX
6	$2,347,816,625,029,715	$2,310,029,256,917,006.50	$17,688	$402.69	+$2347816625.01M → BXRX
7	$146,039,627,186,550,560	$143,527,463,397,768,750.00	$19,338	$412.07	+$146039627186.53M → BXRX
8	$8,499,944,982,314,035,000	$8,343,682,581,224,426,000.00	$21,113	$421.04	+$8499944982314.01M → BXRX
9	$462,952,314,342,881,700,000	$453,857,373,211,805,700,000.00	$23,020	$429.61	+$462952314342881.69M → BXRX
10	$23,597,687,873,458,490,000,000	$23,102,328,897,111,608,000,000.00	$25,070	$437.78	+$23597687873458488.00M → BXRX

BXRX vs DVY: Complete Analysis 2026

BXRX — Stock

Baudax Bio, Inc., a pharmaceutical company, develops and commercializes products for hospital and other acute care settings. The company offers ANJESO (meloxicam) injection for the management of moderate to severe pain, alone or in combination with non-NSAID analgesics. Its products under development includes BX1000, an intermediate-acting neuromuscular blocking agent (NMB) that is in phase II clinical trial; BX2000, an ultra- short acting NMBA, which is in phase I clinical trial; BX3000, an NMBA reversal agent; and Dex-IN, a proprietary intranasal formulation of dexmedetomidine. The company was incorporated in 2019 and is based in Malvern, Pennsylvania.

Full BXRX Calculator →

DVY — ETF

The iShares Select Dividend ETF seeks to track the investment results of an index composed of relatively high dividend paying U.S. equities.

Full DVY Calculator →

📬

Get this BXRX vs DVY comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

BXRX vs SCHD BXRX vs JEPI BXRX vs O BXRX vs KO BXRX vs MAIN

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.